共 50 条
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
被引:0
|作者:
B Ballester
O Ramuz
C Gisselbrecht
G Doucet
L Loï
B Loriod
F Bertucci
R Bouabdallah
E Devilard
N Carbuccia
M-J Mozziconacci
D Birnbaum
P Brousset
F Berger
G Salles
J Briére
R Houlgatte
P Gaulard
L Xerri
机构:
[1] TAGC,Département de Biopathologie
[2] INSERM ERM206,Département d’Hémato
[3] Institut Paoli-Calmettes,Pathologie
[4] Université de la Méditerranée,Département d’Oncologie Moléculaire
[5] CHU Saint-Louis,Département de Pathologie
[6] Groupe d'Etude des Lymphomes de l'Adulte (GELA),Département de Pathologie
[7] Institut d'Hématologie,undefined
[8] Hôpital Saint-Louis,undefined
[9] Institut Paoli-Calmettes,undefined
[10] CHU Purpan,undefined
[11] Département de Pathologie,undefined
[12] Département d'Hématologie,undefined
[13] INSERM U 617,undefined
[14] Hôpital Henri Mondor,undefined
来源:
关键词:
T-cell lymphoma;
gene expression profiling;
microarray;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
The classification of peripheral T-cell lymphomas (PTCL) is still a matter of debate. To establish a molecular classification of PTCL, we analysed 59 primary nodal T-cell lymphomas using cDNA microarrays, including 56 PTCL and three T-lymphoblastic lymphoma (T-LBL). The expression profiles could discriminate angioimmunoblastic lymphoma, anaplastic large-cell lymphoma and T-LBL. In contrast, cases belonging to the broad category of ‘PTCL, unspecified’ (PTCL-U) did not share a single molecular profile. Using a multiclass predictor, we could separate PTCL-U into three molecular subgroups called U1, U2 and U3. The U1 gene expression signature included genes known to be associated with poor outcome in other tumors, such as CCND2. The U2 subgroup was associated with overexpression of genes involved in T-cell activation and apoptosis, including NFKB1 and BCL-2. The U3 subgroup was mainly defined by overexpression of genes involved in the IFN/JAK/STAT pathway. It comprised a majority of histiocyte-rich PTCL samples. Gene Ontology annotations revealed different functional profile for each subgroup. These results suggest the existence of distinct subtypes of PTCL-U with specific molecular profiles, and thus provide a basis to improve their classification and to develop new therapeutic targets.
引用
收藏
页码:1560 / 1570
页数:10
相关论文